.Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BX04_PerindoprilBisoprololAndAmlodipi.PerindoprilBisoprololAndAmlodipi .Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BX04_PerindoprilBisoprololAndAmlodipi.PerindoprilBisoprololAndAmlodipi| name: | PerindoprilBisoprololAndAmlodipine |
| ATC code: | C09BX04 | route: | oral |
| n-compartments | 1 |
This fixed-dose combination contains perindopril (an ACE inhibitor), bisoprolol (a selective beta1-blocker), and amlodipine (a calcium channel blocker). The combination is used for the management of hypertension and prevention of cardiovascular events, especially in patients who may benefit from multi-mechanism antihypertensive therapy. It is currently used and approved in various regions.
Pharmacokinetic parameters estimated based on published data of the individual components in healthy adults; no direct publication for the fixed-dose triple combination found.